male and female patient will be eligible for enrollment female should be either of non-childbearing potential a a result of surgery radiational therapy menopause one year post onset or of childbearing potential and practice a medically acceptable method of contraception eg abstinence a barrier method plus spermicide or intrauterine device iud for at least three month before visit 1 screening and for two month after the end of the study they must also have a negative serum beta-human chorionic gonadotropin beta-hcg at screening pregnant and/or lactating female be exclude those woman use an oral contraceptive must also be use an additional approved method of contraception eg a barrier method plus spermicide or iud starting with the baseline phase and continue throughout the entire study period 